MT-RNR2 and infection: The SOSV survivor’s potent Ab response at 5 years after infection (presumably without reexposure to virus while living in the United States) to both F and HN glycoproteins is remarkable and suggests the possibility for inducing durable vaccine-induced durable functional immunity in humans should the need ever arise.